Officials and government ministers will invite bosses from companies including AstraZeneca (AZN) and GSK (GSK) to form a new panel with the UK government aimed at devising a new pricing regime for key medicines following this week’s announcement of a new drug-pricing deal with the U.S., reported Sky News’ Mark Kleinman.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AZN:
- AstraZeneca baxdrostat NDA accepted for priority review by FDA
- AstraZeneca announces NDA for baxdrostat accepted for Priority Review by FDA
- Vaccine committee considers changes to childhood schedule, NY Times reports
- Midday Fly By: Nvidia invests in Synopsys, U.S. strikes pharma deal with UK
- Trump Trade: U.S. confirms agreement with U.K. on pharmaceutical pricing